Chemed Corp. 2005 Annual Report (10-K) Summary
Business Context and Reporting Period
Company: Chemed Corporation (NYSE: CHE)
Reporting Period: Fiscal year ended December 31, 2005
Segments: The Company operates in two primary segments:
- Vitas Group: The nation's largest provider of hospice services, operating 39 programs in 15 states. Over 90% of revenue is derived from Medicare and Medicaid.
- Roto-Rooter Group: A provider of sewer, drain, and pipe cleaning, HVAC, and plumbing repair services, operating 72 facilities in 26 states.
Key Financial Metrics
Note: Specific revenue, net income, and cash flow totals for 2005 are incorporated by reference from the Annual Report to Stockholders and are not explicitly stated in the provided text. The following metrics are available:
- Debt Structure: As of December 31, 2005, the Company had $84.4 million in variable rate debt outstanding. Total long-term debt carrying value was approximately $235.1 million, with a market value of $244.1 million.
- Interest Rate Risk: A 100 basis point change in interest rates would impact annual interest expense by approximately $844,000.
- Equity: As of March 8, 2006, 26,236,872 shares of capital stock were outstanding. The aggregate market value of voting stock held by non-affiliates was approximately $1.05 billion (as of June 30, 2005).
- Dividends: The Company paid $0.06 per share in dividends for each quarter of 2005.
- Allowances for Doubtful Accounts: The balance decreased from $7,544,000 at the beginning of 2005 to $8,413,000 at year-end, with $7,224,000 charged to costs and expenses.
Material Changes and Unusual Items
- Discontinued Operations: The Service America segment was discontinued in 2005. Assets were sold to employees in May 2005, with the acquiring entity assuming substantially all liabilities. A receivable of approximately $4.7 million was created, with $1 million paid at closing and the remainder payable over 11 months.
- Seasonality: Roto-Rooter results are impacted by fourth-quarter advertising costs. In Q4 2005, $6.3 million in advertising costs were expensed, representing 33.5% of the full-year total.
- Legal Settlements:
- Roto-Rooter Class Action: A settlement was reached regarding unlicensed plumbing work in Illinois. The Company accrued $3.1 million for the anticipated cost.
- Vitas Wage Claim: A settlement was reached regarding overtime and meal/break violations for California employees. The agreement is for $19 million, inclusive of fees and administration costs.
- Environmental Liabilities: An accrual of $3.0 million exists for potential environmental cleanup costs related to the former DuBois Chemicals subsidiary. The Company is contingently liable for up to $16 million but does not believe payment of the additional amount is probable.
Guidance, Risks, and Contingencies
Regulatory and Legal Risks (Vitas):
- OIG Investigation: In April 2005, the Office of Inspector General (OIG) served civil subpoenas regarding alleged improper billing of Medicare and Medicaid. A qui tam complaint is under seal. The Company has recorded $564,000 in pretax expenses for the nine months ended September 30, 2005, related to this matter. The outcome is unpredictable.
- Reimbursement Risk: Vitas is highly dependent on Medicare and Medicaid (approx. 95% of revenue). Changes in per diem rates, eligibility rules (e.g., the six-month life expectancy certification), or payment caps (e.g., the Phoenix, AZ facility exceeded the overall hospice cap in 2005) could materially impact profitability.
- Compliance: Risks include violations of Anti-Kickback laws, Stark Law, and False Claims Act provisions, which could result in fines, exclusion from programs, or treble damages.
- Leverage: High debt levels limit cash flow available for operations and restrict the ability to obtain additional financing or make acquisitions. Debt covenants restrict dividends, asset sales, and capital expenditures.
- Competition: Both segments face intense competition. Roto-Rooter competes in a fragmented market; Vitas competes with non-profits and other national providers.
- Workforce: Vitas faces a nationwide shortage of qualified nurses, potentially driving up wage costs and impacting service quality.
Management believes disclosure controls and procedures are effective. The Company continues to pursue growth through organic expansion and acquisitions, particularly for Vitas, though regulatory hurdles for non-profit acquisitions remain a risk.
Investor Verification Checklist
- OIG Investigation Outcome: Verify the status of the OIG investigation and the sealed qui tam complaint, as the financial impact is currently unknown but could be material.
- Reimbursement Rate Changes: Monitor annual Medicare/Medicaid rate adjustments and any legislative changes to the "per diem" payment model or eligibility criteria.
- Debt Covenant Compliance: Review the Company's ability to meet financial covenants given the high leverage from the Vitas acquisition and the impact of interest rate fluctuations on variable debt.
- Legal Settlement Finalization: Confirm the final court approval and payment terms for the $3.1 million Roto-Rooter settlement and the $19 million Vitas wage claim settlement.
- Environmental Exposure: Assess if the $3.0 million environmental accrual for DuBois Chemicals is sufficient given the potential $16 million contingent liability.